This liquid formulation contains 10mg of Thymosin Beta-4 and 5mg of Body Protective Compound 157 per vial, providing a potent regenerative peptide blend for tissue healing and inflammation support
The Phase 2 ACT-AD trial (NCT04491006) in mild-to-moderate Alzheimers disease failed its primary endpoint in June 2022
, Grigolo, G
INGREDIENTS Water, L-carnitine, fructose, acid (citric acid), preservative (potassium sorbate), sweeteners (sodium cyclamate, acesulfame K, sodium saccharin), natural flavouring, vitamin B6 (pyridoxine hydrochloride)
Combining CLA and L-Carnitine may be the secret weapon you need
By the third day, hemodialysis had reduced ammonia levels to 98 mol/L, which led to moderate recovery from coma and generalized convulsions